August 2026 · 7 min read
Both rHSA and BSA are albumin proteins used as serum replacements in cell culture, DMPK assay buffers, and IVD applications. They are not interchangeable. The choice between them determines whether your medium is animal-free, how well your cells grow, and whether your drug-protein binding data is physiologically relevant.
What albumin actually does in cell culture
Albumin is the most abundant protein in serum — approximately 60% of total serum protein. It performs three essential functions that no single growth factor can replace:
- Fatty acid carrier: Albumin binds and transports long-chain fatty acids to cells. Without albumin, fatty acids are not soluble in aqueous medium and cells become lipid-deficient.
- ROS scavenger: Albumin’s free thiol group (Cys-34) scavenges reactive oxygen species, protecting cells from oxidative damage during culture.
- Drug and small molecule binding: Albumin modulates the free concentration of lipophilic drugs, hormones, and vitamins in culture medium — a critical variable in DMPK and cytotoxicity assays.
When you remove serum from your medium, albumin is the single component most likely to limit cell survival if not replaced.
BSA — Bovine Serum Albumin
BSA is extracted from bovine blood — typically from the same processing stream as FBS or adult cattle serum. It is the most widely used albumin in cell culture and biochemistry due to its low cost and commercial availability in large quantities.
BSA grades available from SeamlessBio
- Standard Grade (>96% purity): General purpose — ELISA blocking, antibody dilution buffers, precipitation reactions, cell culture at 1–5 mg/mL
- Low Endotoxin (<1 EU/mg): For cytokine assays, cell-based assays, receptor binding studies where endotoxin would confound results
- Fatty Acid Free (FAF): Sterol and fatty acid removed — for receptor and lipid studies, PPAR assays, microsomal protein binding correction (fu,mic), IVF medium
Where BSA is the correct choice
- Non-human cell lines (CHO, HEK293, rodent cells) where human-origin albumin provides no advantage
- ELISA blocking buffers, western blot blocking
- DMPK microsomal assays — BSA FAF for fu,mic correction (standard industry practice)
- IVF fertilisation medium — BSA FAF at 3–6 mg/mL (standard for bovine and porcine IVF)
- Cost-sensitive high-volume applications where animal-origin is acceptable
rHSA — Recombinant Human Serum Albumin
rHSA is produced recombinantly — typically in rice (Oryza sativa, OsrhHSA) or yeast (Pichia pastoris) expression systems. It has identical amino acid sequence to human serum albumin but is produced without animal donors or plasma fractionation. SeamlessBio supplies OsrhHSA (rice-expressed, ≥95% purity) as the standard rHSA product.
Key advantages of rHSA over BSA
- Animal-free / xeno-free: No bovine components — required for GMP cell therapy manufacturing and ATMP applications
- No virus risk: Recombinant production eliminates the risk of adventitious agents from animal-derived raw materials
- Human sequence: Identical binding sites to endogenous HSA — more relevant for human cell cultures and DMPK protein binding assays
- Defined lot-to-lot consistency: Recombinant production gives lower batch-to-batch variation than plasma-derived albumin
- GMP-grade available: Suitable for clinical manufacturing documentation requirements
Where rHSA is the correct choice
- ATMP and cell therapy manufacturing: MSC expansion, CAR-T manufacturing, iPSC culture — any xeno-free protocol
- Serum-free AAV production: rHSA at 1–2 g/L stabilises viral particles during harvest and purification
- Human DMPK protein binding: fu,plasma assays where human albumin binding properties are required (BSA has different drug binding affinity from HSA for many compounds)
- Cryopreservation media: xeno-free cryopreservation of clinical-grade cell products
- IVD calibrator development: when a human-sequence albumin matrix is required for physiological relevance
- Serum-free formulation with recombinant growth factors: the albumin base for defined serum-free media
Full comparison table
| Parameter | BSA (Standard) | BSA Fatty Acid Free | rHSA |
|---|---|---|---|
| Origin | Bovine blood | Bovine blood, processed | Recombinant (rice or yeast) |
| Animal-free? | No | No | Yes |
| Sequence | Bovine (76% homology to HSA) | Bovine | Human (identical to native HSA) |
| Fatty acid content | Present — variable | Removed (<0.005%) | Low — lot-specific |
| Drug binding affinity | Differs from HSA for many drugs | Differs from HSA | Human — relevant for DMPK |
| Lot-to-lot consistency | Medium | Medium-high | High (recombinant) |
| GMP-grade available? | Partial | Partial | Yes |
| Cost | Low | Medium | High |
| Best for | Blocking, general cell culture, non-human cells | IVF, fu,mic correction, lipid studies | ATMP, xeno-free, human DMPK, AAV production |
The DMPK protein binding question — BSA vs rHSA
This is the most practically important difference for DMPK scientists. BSA and HSA have different drug binding site affinities. Site I (warfarin site) and Site II (diazepam site) have different amino acid compositions in bovine vs human albumin — meaning the fu,plasma measured in BSA solution is not equivalent to fu,plasma in human plasma for many drugs, particularly acidic compounds.
For fu,mic correction in microsomal assays, BSA FAF is the industry standard — its binding removes lipids that would otherwise partition compound into the microsomal membrane, improving IVIVE. The specific albumin sequence matters less here.
For fu,plasma measurement (equilibrium dialysis or RED assay) — use human plasma or rHSA solution if you need defined albumin without other plasma proteins. BSA gives systematically different values for many drugs and is not appropriate for clinical fu,plasma estimation.
Available from SeamlessBio
- BSA Standard Grade — >96% purity, cost-effective for blocking and general use
- BSA Low Endotoxin — <1 EU/mg for cell-based and cytokine assays
- BSA Fatty Acid Free — for IVF, DMPK fu,mic, lipid studies
- rHSA (OsrhHSA) — rice-expressed, ≥95% purity, xeno-free, animal-free
Further reading:
